STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #735 by analyst upside · 2026-08-13
CVRX
CVRx, Inc.
Healthcare · Market Cap $73M · P/E 0x
ANALYST PRICE TARGET
+116.7%
implied upside to consensus target
Current Price $2.73
Consensus Target $5.92
Bull Target $13.0
Bear Target $3.5
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
3
Hold
3
Sell
0
52-Week Low $2.2
52-Week High $11.3
YTD Return -61.5%
FUNDAMENTALS
Market Cap $73M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-2.06
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $61M
Profit Margin -84.9%
52-WEEK RANGE
52-Week Low $2.2
52-Week High $11.3
Current Price $2.73
Bear Target $3.5
Bull Target $13.0
● Now $2.73 ● Target $5.92
TRADING DATA
Avg Volume 617K
YTD Return -61.5%
Analyst Count 6
Consensus Buy
Upside to Target +116.7%
Last Updated 2026-08-13

ANALYST SUMMARY

CVRx, Inc. (CVRX) is currently trading at $2.73 with a Wall Street consensus price target of $5.92, implying potential upside of 116.7% over the next 12 months. 6 analysts currently cover CVRX, with a consensus rating of Buy - 50% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $13.0, while the most cautious has a target of $3.5.

CVRX operates in the Healthcare sector with a market capitalisation of $73M. The stock is down 61.5% year-to-date and is currently trading near the lower end of its 52-week range of $2.2 – $11.3.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for CVRX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity - Reiterated
Buy → Buy 2026-04-14 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2026-02-13 Building track record
Canaccord Genuity - Reiterated
Buy → Buy 2025-11-06 Building track record
Cantor Fitzgerald - Reiterated
Overweight → Overweight 2025-11-06 40% win rate (10 calls)
Cantor Fitzgerald reit
Overweight → Overweight 2025-08-05 40% win rate (10 calls)
Piper Sandler - Reiterated
Overweight → Overweight 2025-05-09 14% win rate (7 calls)
JP Morgan ↓ Downgrade
Neutral → Underweight 2025-05-09 43% win rate (7 calls)
Lake Street - Reiterated
Buy → Buy 2025-04-08 27% win rate (11 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
22
out of 100
Coverage depth
15/30
Consensus clarity
0/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →